NATR vs NBIX · P/E 29, rev $239.9M vs P/E 45, rev $1.77B
Natures Sunshine Products Inc (NATR) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Natures Sunshine Products Inc (NATR) is a packaged foods company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported NATR revenue for 2026-06-30 was $239.9M. Net income was $8.7M. Revenue was up 95.2% from 2026-03-31 to 2026-06-30. NATR currently screens at market cap $287.8M and trailing P/E 29.4.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
NATR currently screens at market cap $287.8M and trailing P/E 29.4. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the NATR and NBIX stock pages for the full models.
Not investment advice.